je.st
news
Tag: clinical trial
Schreiner MediPharm assists Sanofi clinical trial with label innovation
2020-05-07 18:48:13| Label and Narrow Web Breaking News
The Booklet-Label for the needle protection system has 32 pages of medicinal information in 22 languages.
Tags: trial
label
clinical
innovation
J&J starts clinical trial of Ebola vaccine in Sierra Leone
2015-10-09 09:51:59| Biotech - Topix.net
Johnson & Johnson said it has begun a safety and immunogenicity clinical trial of a preventive Ebola vaccine regimen in Sierra Leone. Patients eat in the recovery wing of the Hastings Ebola treatment centre in a neighborhood in Freetown December 21, 2014.
Tags: trial
starts
clinical
sierra
J&J starts clinical trial of Ebola vaccine in Sierra Leone
2015-10-09 09:38:50| Food - Topix.net
Johnson & Johnson said it has begun a safety and immunogenicity clinical trial of a preventive Ebola vaccine regimen in Sierra Leone. Patients eat in the recovery wing of the Hastings Ebola treatment centre in a neighborhood in Freetown December 21, 2014.
Tags: trial
starts
clinical
sierra
SYNDAX AND MERCK ANNOUNCE FIRST PATIENTS DOSED IN PHASE 1b/2 CLINICAL TRIAL OF ENTINOSTAT AND KEYTRUDA
2015-09-28 14:00:56| Merck.com - Product News
Dateline City: WALTHAM, Mass. and KENILWORTH, N.J. Clinical trial to assess safety and efficacy of immuno-oncology combination in patients with advanced NSCLC or melanoma WALTHAM, Mass. and KENILWORTH, N.J. Syndax Pharmaceuticals, Inc. and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the dosing of the first patients in the Phase 1b/2 clinical trial of Syndaxs entinostat in combination with Mercks anti-PD-1 therapy KEYTRUDA (pembrolizumab) in patients with non-small cell lung cancer (NSCLC) or melanoma. Language: English read more
PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer
2015-09-15 15:58:58| Biotech - Topix.net
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , discussed today some of the major "milestone" tasks that must be completed to begin its Phase 2b clinical trial in pancreatic cancer. The trial will test the effectiveness and safety of PharmaCyte Biotech's pancreatic cancer treatment.